The global infection control market is expected to grow at a CAGR of 6.5% during the forecast period of 2016 to 2021. The market is poised to reach USD 17.78 billion by 2021 from USD 13.00 billion in 2016. The market is primarily driven by growth in the number of surgical procedures, growing aging population, rising incidence of hospital acquired infections (HAIs), and rising focus on the need of food sterilization and disinfection.
In this report, the infection control market is segmented on the basis of product type, end user, and geography. On the basis of product type, the market is primarily segmented into disinfection products and sterilization products. The disinfection products market is further sub-segmented into disinfectors, endoscope reprocessors, disinfectants, and medical non-wovens. The disinfectors market is further sub-segmented into sub-segmented into washer disinfector, flusher disinfectors, and UV rays disinfectors; whereas on the basis of disinfectants the market is sub-segmented into hand disinfectants, skin disinfectants, instrument disinfectants, and surface disinfectants. The sterilization products market is sub-segmented into sterilization methods and contract sterilization. On the basis of sterilization method, the market is further sub-segmented into heat sterilization, low temperature sterilization, filtration sterilization, and radiation sterilization. The end user market is sub-segmented into hospitals, medical device companies, lifesciences companies, food industry, pharmaceutical companies, and other end users.
In 2015, the disinfection products accounted for the largest share of the infection control market. The large share of the disinfection market can be attributed to the large-scale use of disinfectors and medical nonwovens in the healthcare industry. However, the sterilization products market is expected to grow at a higher CAGR during the forecast period due to growing emphasis on infection control policies within hospital premises and strengthening of government regulations for quality of healthcare services delivered.
In 2015, North America accounted for the largest share of the global infection control market, followed by Europe, Asia-Pacific, Latin America, and Middle East and Africa. Asia-Pacific is expected to be the fastest-growing region during the forecast period, due to rising incidences of HAIs and increasing medical tourism in emerging countries such as China and India.
Some of the key players operating in this market include Getinge Group (Sweden), Advanced Sterilization Products (U.S.), STERIS Corporation (U.S.), 3M Company (U.S.), Belimed AG (Switzerland), Halyard Health, Inc. (U.S.), Sterigenics International, Inc. (U.S.), MMM Group (Germany), Cantel Medical Corporation (U.S.), and Matachana Group (Spain).
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms, and allow them to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use one or a combination of the below-mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by top players in the infection control market. The report analyzes the infection control market by product type, end users, and region
- Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the infection control market
- Market Development: Comprehensive information about lucrative emerging markets by product and region
- Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the infection control market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and manufacturing capabilities of leading players in the infection control market.